Citi analyst Tyler Radke raised the firm’s price target on DocuSign to $87 from $86 and keeps a Buy rating on the shares following the Q2 report. A small billings beat but a larger revenue and profitability beat offered more signs of validation that Docusign continues to stabilize growth and find incremental efficiency, the analyst tells investors in a research note. The firm remains encouraged by DocuSign’s “various growth signals.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU: